B. Braun Launches ACCEL®: Pioneering Interventional Systems

B. Braun Interventional Systems Inc. (BIS), a member of the B. Braun Group of Companies, announced today the launch of its new ACCEL® All-Purpose and Biliary Drainage Catheters with TrueGlide® Hydrophilic Coating for percutaneous drainage.

The ACCEL All-Purpose and Biliary Drainage Catheters are designed for optimal patient comfort and clinical care. The catheter features large oval holes designed to maximize fluid drainage volume, while the TrueGlide Hydrophilic Coating helps with a smooth catheter insertion.

Dave Mittl, Vice President of BIS

“We are excited to expand our percutaneous drainage portfolio of products with the ACCEL All-Purpose and Biliary Drainage Catheters, now offering a full-system drainage solution to our customers and bringing value to their drainage procedures. Our comprehensive portfolio of sizes and configurations is designed to meet patients’ various drainage needs to help improve outcomes.”

Over the last two decades, BIS has continuously expanded its percutaneous drainage product offerings, responding to the market needs and bringing solutions focused on increasing the value, safety and efficiency of drainage procedures. The latest addition of the all-purpose and biliary drainage catheters completes the portfolio as a full-system drainage solution, providing convenience and options for percutaneous fluid drainage management.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version